Haemonetics Corporation (HAE)

Last Closing Price: 76.66 (2025-07-14)

Net Income (Quarterly)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Haemonetics Corporation (HAE) had Net Income of $57.98M for the most recently reported fiscal quarter, ending 2025-03-31.

Figures for fiscal quarter ending 2025-03-31
Income Statement Financials
$330.60M
Net Income
$57.98M
$137.55M
$193.05M
$259.26M
$71.33M
$-0.60M
$70.74M
$70.74M
$57.98M
$57.98M
$57.98M
$57.98M
$71.33M
$102.18M
50.33M
50.73M
$1.17
$1.17
Balance Sheet Financials
$934.98M
$284.05M
$1.52B
$2.45B
$578.11M
$921.23M
$1.05B
$1.63B
$820.84M
$-239.18M
$820.84M
48.22M
Cash Flow Statement Financials
$181.72M
$-161.90M
$108.82M
$178.80M
$306.76M
$127.96M
$29.64M
--
--
Fundamental Metrics & Ratios
1.62
--
--
0.53
1.49
58.39%
21.58%
21.58%
--
21.40%
17.54%
$165.70M
--
--
--
0.13
0.38
1.63
55.17
7.06%
-24.24%
2.37%
3.33%
$17.02
$3.27
$3.58